<DOC>
	<DOCNO>NCT02364466</DOCNO>
	<brief_summary>Prospective , observational cohort study peripheral T cell lymphoma . Purpose investigate complication include febrile neutropenia era pegylated G-CSF prophylaxis .</brief_summary>
	<brief_title>Cohort Peripheral T Cell Lymphoma</brief_title>
	<detailed_description>Prospective evaluation frequency febrile neutropenia infectious complication homogeneous population patient peripheral T cell lymphoma</detailed_description>
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Lymphoma , T-Cell</mesh_term>
	<mesh_term>Neutropenia</mesh_term>
	<mesh_term>Lymphoma , T-Cell , Peripheral</mesh_term>
	<mesh_term>Febrile Neutropenia</mesh_term>
	<criteria>1 . Treatment naive peripheral T cell lymphoma Subtypes following : Anaplastic large cell lymphoma angioimmunoblastic T cell lymphoma Peripheral T cell lymphomaNOS Enteropathyassociated T cell lymphoma Hepatosplenic Tcell lymphoma Subcutaneous panniculitislike Tcell lymphoma Primary cutaneous gammadelta Tcell lymphoma Primary cutaneous CD8+ aggressive epidermotropic lymphoma 2 . Scheduled receive chemotherapy curative intent 3 . 19 year old 4 . Expected survival 6 month 5 . Informed consent 1 . Other histology describe Extranodal NK/T cell lymphoma Other peripheral T cell lymphoma 2 . Other combined malignancy 3 . Previous history chemotherapy radiation therapy 4 . No informed consent</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2015</verification_date>
</DOC>